The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Linklaters Business Services

Living Wage
ONE SILK STREET, LONDON, EC2Y 8HQ, ENGLAND
Tel:
Work 020 7456 2000
Fax:
Fax 020 7456 2222
DX:
10 LONDON CITY EC3
Email:
Web:
https://www.linklaters.com
Abu Dhabi, Amsterdam, Antwerp, Bangkok, Beijing, Berlin and 25 more

Matthew Bland

Tel:
Work 020 7456 5516
Email:
Linklaters Business Services

Work Department

Corporate.

Position

Matthew is a corporate partner based in the London office. He advises on a wide range of corporate, corporate finance and commercial matters across various sectors but with a focus on the bank and financial institutions and pharmaceuticals sector. His main areas of practice include domestic and international mergers and acquisitions (both private and public), where he has particular experience leading complex and cross-border transactions, corporate restructurings and joint ventures, as well as domestic and international initial public offerings, rights issues and other equity capital markets transactions. Key clients include Lloyds Banking Group, TSB, Rothesay Life, Goldman Sachs, Julius Baer, Novartis, Spirent Communications and Thames Water.

Career

Trainee – Linklaters London – 1998-2000

Associate – Linklaters London – 2000-02

Associate – Linklaters Tokyo – 2002-04

Managing Associate – Linklaters London – 2004-08

Partner – Linklaters London – 2008 to date

Education

Girton College, Cambridge University (1996 BA law); College of Law, Guildford (1997).


London: TMT (technology, media and telecoms)

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

Linklaters LLP's practice is divided into competition, corporate and TMT-related work, with Aisling Zarraga and Marly Didizian at the fore. Zarraga heads the corporate team and other key members include James Inglis and Matthew Bland. Didizian works at the helm of the TMT team with other notable names such as Ian Karet, Nigel Jones and Yohan Liyanage. Liyanage defended Regeneron and Sanofi in an appeal regarding the sale of the cholesterol drug Praluent due to patent infringement. Karet is acting for Merck & Co in its trade mark dispute with Merck KGaA regarding the Merck name. Key members of the competition team include Nicole Kar and Sir Christopher Bellamy.

[back to top]


Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to